Ochi Toshiki 越智俊元

… Alternative Names

越智俊元オチトシキ

Less

Researcher Number	10571086
Other IDs
Affiliation (Current)	2025: 愛媛大学, 医学系研究科, 講師
Affiliation (based on the past Project Information) *help	2016 – 2024: 愛媛大学, 医学系研究科, 講師 2012: 愛媛大学, 医学部附属病院, その他 2011: 愛媛大学, 医学部附属病院, 専攻医 2010: 愛媛大学, 医学部附属病院, 医員
Review Section/Research Field	Principal Investigator Basic Section 54010:Hematology and medical oncology-related / Hematology Except Principal Investigator Basic Section 54010:Hematology and medical oncology-related
Keywords	Principal Investigator がん免疫療法 / 一本鎖抗体 / キメラ抗原受容体 / 共受容体 / 免疫療法 / 自己免疫 / 腫瘍免疫 / IL-2 / サイトカイン / 造血器腫瘍 … More / 改変抗体 / 二重特異性抗体 / 免疫グロブリン遺伝子ライブラリー / トランスレーショナルリサーチ / scFvライブラリー / NY-ESO-1 / Aurora-A特異的TCR導入T細胞 / Aurora-Aペプチドワクチン / Aurora-A … More Except Principal Investigator CAR-T細胞 / がん免疫療法 / Siglec-15 / 1本鎖抗体 / 免疫チェックポイント / キメラ抗原受容体 / 遺伝子改変 / 抗体改変技術 / 二重特異性抗体 / 改変抗体 / 遺伝子改変T細胞 / CD19 / NY-ESO-1 / 一本鎖抗体ライブラリー / キメラ抗原受容体 (CAR) / 一本鎖抗体 Less

新たなT細胞活性化シグナルに基づく新規キメラ抗原受容体の開発研究Principal Investigator
- Principal Investigator
  
  越智俊元
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Ehime University
Development of multifunctional CAR-T cell therapy using novel manufacturing technology of scFv
- Principal Investigator
  
  安川正貴
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Ehime Prefectural University of Health Science
Development of a novel single-chain antibody which regulates cytokine signalingPrincipal Investigator
- Principal Investigator
  
  Ochi Toshiki
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Ehime University
Development of Next-Generation Immunotherapy using Antitumor Antibodies armed with Bridging-BiTE against Refractory TumorsPrincipal Investigator
- Principal Investigator
  
  Ochi Toshiki
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Ehime University
Development and clinical application of cancer-specific single-chain antibody using new technology of antibody modification
- Principal Investigator
  
  YASUKAWA MASAKI
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Ehime Prefectural University of Health Science
  Ehime University
Generation of chimeric antigen receptors with different reactivity for a tumor antigenPrincipal Investigator
- Principal Investigator
  
  Ochi Toshiki
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Research Field
  
  Hematology
- Research Institution
  Ehime University
Aurora－Aを標的とした包括的がん免疫療法の開発Principal Investigator
- Principal Investigator
  
  越智俊元
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Hematology
- Research Institution
  Ehime University

All 2023 2022 2021 2020 2019 2018 2017 2011 2010

All Journal Article Presentation Book Patent

[Book] Methods in Molecular Biology.2019
- Author(s)
  Ochi T, Maruta M, Hirano N.
- Total Pages
  267
- Publisher
  Springer
- ISBN
  9781493997275
- Data Source
  KAKENHI-PROJECT-18K08331
[Book] 血液疾患最新の治療2020-20222019
- Author(s)
  越智俊元
- Total Pages
  384
- Publisher
  南江堂
- ISBN
  9784524249787
- Data Source
  KAKENHI-PROJECT-18K08331
[Book] 実験医学2019
- Author(s)
  越智俊元, 安川正貴
- Total Pages
  267
- Publisher
  羊土社
- ISBN
  9784758103817
- Data Source
  KAKENHI-PROJECT-18K08331
[Journal Article] Reinforced antimyeloma therapy via dual-lymphoid activation mediated by a panel of antibodies armed with bridging-BiTE2023
- Author(s)
  Konishi Tatsuya、Ochi Toshiki、Maruta Masaki、Tanimoto Kazushi、Miyazaki Yukihiro、Iwamoto Chika、Saitou Takashi、Imamura Takeshi、Yasukawa Masaki、Takenaka Katsuto
- Journal Title
  
  Blood
  
  Volume: 142 Issue: 21 Pages: 1789-1805
- DOI
  10.1182/blood.2022019082
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08462, KAKENHI-PROJECT-21K15569, KAKENHI-PROJECT-21H02949
[Journal Article] A single-chain antibody generation system yielding CAR-T cells with superior antitumor function2021
- Author(s)
  Ochi Toshiki、Maruta Masaki、Tanimoto Kazushi、Kondo Fumitake、Yamamoto Toshihiro、Kurata Mie、Fujiwara Hiroshi、Masumoto Junya、Takenaka Katsuto、Yasukawa Masaki
- Journal Title
  
  Communications Biology
  
  Volume: 4 Issue: 1 Pages: 273-273
- DOI
  10.1038/s42003-021-01791-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K07376, KAKENHI-PROJECT-18H02839, KAKENHI-PROJECT-20H03719, KAKENHI-PROJECT-18K08361, KAKENHI-PROJECT-21H02949, KAKENHI-PROJECT-21K15569
[Journal Article] Development of innovative T-cell immunotherapy for hematological malignancies2019
- Author(s)
  Ochi T
- Journal Title
  
  Rinsho Ketsueki
  
  Volume: 60 Issue: 7 Pages: 824-833
- DOI
  10.11406/rinketsu.60.824
- NAID
  130007687999
- ISSN
  0485-1439, 1882-0824
- Language
  Japanese
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K08331
[Journal Article] 造血器腫瘍に対する免疫療法　新たな標的抗原とその治療応用2019
- Author(s)
  越智俊元, 安川正貴
- Journal Title
  
  実験医学
  
  Volume: 37 Pages: 2622-2626
- Data Source
  KAKENHI-PROJECT-18H02839
[Journal Article] Direct comparisoin of target-reactivity and cross-reactivity induced by CAR-and BiTE-redirected T cells for the development of antibody-based T-cell therapy.2019
- Author(s)
  Masaki Maruta, Toshiki Ochi, Kazushi Tanimoto, Hiroaki Asai, et al.
- Journal Title
  
  Scientific reports
  
  Volume: 9 Issue: 1 Pages: 13293-13293
- DOI
  10.1038/s41598-019-49834-2
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08330, KAKENHI-PROJECT-18K08331, KAKENHI-PROJECT-18K08361, KAKENHI-PROJECT-18H02839, KAKENHI-PROJECT-18H02840, KAKENHI-PROJECT-17K09957
[Journal Article] 遺伝子改変抗体を応用したがんに対する T細胞免疫療法2018
- Author(s)
  越智俊元
- Journal Title
  
  愛媛医学
  
  Volume: 37
- Data Source
  KAKENHI-PROJECT-16H07025
[Journal Article] 白血病幹細胞の免疫細胞治療2018
- Author(s)
  越智俊元
- Journal Title
  
  血液フロンティア
  
  Volume: 6
- Data Source
  KAKENHI-PROJECT-16H07025
[Journal Article] Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked anti-leukemia reactivity and safety2011
- Author(s)
  Ochi T, et al
- Journal Title
  
  Blood
  
  Volume: 118(6) Issue: 6 Pages: 1495-503
- DOI
  10.1182/blood-2011-02-337089
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591245, KAKENHI-PROJECT-22790913, KAKENHI-PROJECT-23659489
[Journal Article] T細胞レセプター遺伝子を用いたがん免疫遺伝子治療のトランスレーショナルリサーチ2011
- Author(s)
  越智俊元
- Journal Title
  
  愛媛医学
  
  Volume: 30 Pages: 6-12
- Data Source
  KAKENHI-PROJECT-22790913
[Journal Article] Requisite considerations for successful adoptive immunotherapy with engineered T-lymphocytes using tumor antigen-specific T-cell receptor gene transfer2011
- Author(s)
  Ochi T, et al
- Journal Title
  
  Expert Opin Biol Ther
  
  Volume: 11(6) Issue: 6 Pages: 699-713
- DOI
  10.1517/14712598.2011.566853
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591245, KAKENHI-PROJECT-22790913, KAKENHI-PROJECT-23659489
[Journal Article] 白血病に対する細胞免疫療法2010
- Author(s)
  越智俊元
- Journal Title
  
  Medical Science Digest
  
  Volume: 36 Pages: 884-887
- Data Source
  KAKENHI-PROJECT-22790913
[Patent] SIGLEC15抗体およびその用途2023
- Inventor(s)
  越智俊元、竹中克斗、山下政克、松岡祐子
- Industrial Property Rights Holder
  越智俊元、竹中克斗、山下政克、松岡祐子
- Industrial Property Rights Type
  特許
- Filing Date
  2023
- Acquisition Date
  2023
- Data Source
  KAKENHI-PROJECT-22K08462
[Patent] CARライブラリ、scFvのスクリーニング方法、抗体またはその結合断片、キメラ抗原受容体、核酸、細胞、および細胞の製造方法2019
- Inventor(s)
  越智俊元、安川正貴、藤原　弘
- Industrial Property Rights Holder
  越智俊元、安川正貴、藤原　弘
- Industrial Property Rights Type
  特許
- Filing Date
  2019
- Data Source
  KAKENHI-PROJECT-18H02839
[Patent] 複合体化タンパク質、抗体複合体、医薬組成物、および核酸2019
- Inventor(s)
  越智俊元、安川正貴、竹中克斗
- Industrial Property Rights Holder
  越智俊元、安川正貴、竹中克斗
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2019-024976
- Filing Date
  2019
- Data Source
  KAKENHI-PROJECT-18K08331
[Patent] CARライブラリおよびscFvの製造方法2019
- Inventor(s)
  越智俊元、安川正貴、竹中克斗、藤原弘
- Industrial Property Rights Holder
  越智俊元、安川正貴、竹中克斗、藤原弘
- Industrial Property Rights Type
  特許
- Filing Date
  2019
- Data Source
  KAKENHI-PROJECT-18H02839
[Patent] 複合体化タンパク質、抗体複合体、医薬組成物、および核酸2019
- Inventor(s)
  越智俊元、安川正貴、竹中克斗
- Industrial Property Rights Holder
  越智俊元、安川正貴、竹中克斗
- Industrial Property Rights Type
  特許
- Filing Date
  2019
- Data Source
  KAKENHI-PROJECT-18K08331
[Presentation] 免疫チェックポイント分子を標的とした新たなCAR-T細胞療法の開発2023
- Author(s)
  越智俊元, 松岡祐子, 小西達矢, 丸田雅樹, 宮崎幸大, 谷本一史, 安川正貴, 山下政克, 竹中克斗
- Organizer
  第15回日本血液疾患免疫療法学会学術集会
- Data Source
  KAKENHI-PROJECT-22K08462
[Presentation] A new CAR-T-cell therapy simultaneously targeting both a tumor antigen and an immune checkpoint.2023
- Author(s)
  Ochi T, Matsuoka Y, Konishi T, Maruta M, Miyazaki Y, Tanimoto K, Yasukawa M, Yamashita M, Takenaka K.
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-22K08462
[Presentation] Development of a New CAR-T-Cell Therapy Targeting an Immune Checkpoint for Effective Treatment of Solid and Liquid Tumors.2023
- Author(s)
  Ochi T, Matsuoka Y, Konishi T, Maruta M, Miyazaki Y, Tanimoto K, Yasukawa M, Yamashita M, Takenaka K.
- Organizer
  The 65th Annual Meeting and Exposition of the American Society of Hematology.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08462
[Presentation] A new CAR-T-cell therapy targeting both tumor antigen and immune checkpoint for effective treatment of solid tumors.2023
- Author(s)
  Ochi T, Matsuoka Y, Konishi T, Maruta M, Miyazaki Y, Tanimoto K, Yasukawa M, Yamashita M, Takenaka K.
- Organizer
  第27回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-22K08462
[Presentation] The role of CD8 molecule involved in the functionality of CAR-T cells2022
- Author(s)
  小西達矢, 越智俊元, 平川直樹, 丸田雅樹, 宮﨑幸大, 谷本一史, 安川正貴, 竹中克斗
- Organizer
  第26回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-22K08462
[Presentation] The role of CD8 molecule in the reactivity of T cells redirected with chimeric antigen receptor2022
- Author(s)
  小西達矢, 越智俊元, 平川直樹, 丸田雅樹, 宮﨑幸大, 谷本一史, 安川正貴, 竹中克斗
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-22K08462
[Presentation] CAR-T細胞の機能性におけるCD8分子の役割2022
- Author(s)
  小西達矢, 越智俊元, 平川直樹, 丸田雅樹, 宮﨑幸大, 谷本一史, 安川正貴, 竹中克斗
- Organizer
  第14回日本血液疾患免疫療法学会学術集会
- Data Source
  KAKENHI-PROJECT-22K08462
[Presentation] 難治性骨髄腫に対する新規治療を目指した次世代型遺伝子改変二重特異性抗体の開発2021
- Author(s)
  小西達矢, 越智俊元, 丸田雅樹, 谷本一史, 齋藤卓, 今村健志, 安川正貴, 竹中克斗
- Organizer
  第13回日本血液疾患免疫療法学会学術集会
- Data Source
  KAKENHI-PROJECT-18K08331
[Presentation] Development of novel bispecific antibodies armed with Bridging-BiTE for targeting a variety of tumors2021
- Author(s)
  Konishi T, Ochi T, Maruta M, Tanimoto K, Saitou T, Imamura T, Yasukawa M, Takenaka K.
- Organizer
  第25回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K08331
[Presentation] Development of innovative antitumor antibodies armed with Bridging-BiTE to advance anti-myeloma immunotherapy2021
- Author(s)
  Konishi T, Ochi T, Maruta M, Tanimoto K, Saitou T, Imamura T, Yasukawa M, Takenaka K.
- Organizer
  第46回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-18K08331
[Presentation] DEVELOPMENT OF NEXT-GENERATION ANTITUMOR ANTIBODIES ARMED WITH BRIDGING-BITE TO ADVANCE ANTI-MYELOMA IMMUNOTHERAPY2021
- Author(s)
  Konishi T, Ochi T, Maruta M, Tanimoto K, Saitou T, Imamura T, Yasukawa M, Takenaka K.
- Organizer
  European Hematology Association
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08331
[Presentation] Optimized scFv-expressing CAR-T cells showed marked antitumor reactivity in vivo2020
- Author(s)
  Ochi T, Maruta M, Tanimoto K, Takenaka K, Yasukawa M.
- Organizer
  第24回日本がん免疫学会学術集会
- Data Source
  KAKENHI-PROJECT-18H02839
[Presentation] 次世代型一本鎖抗体作製技術に基づき調整したCAR-T細胞を用いた有効かつ安全な免疫療法の開発2020
- Author(s)
  越智俊元, 丸田雅樹, 谷本一史, 倉田美恵, 増本純也, 竹中克斗, 安川正貴.
- Organizer
  第12回日本血液疾患免疫療法学会学術集会
- Data Source
  KAKENHI-PROJECT-18H02839
[Presentation] Fine-tuned scFv-expressing CAR-T cells show marked antitumor reactivity in vivo.2020
- Author(s)
  Ochi T, Maruta M, Tanimoto K, Kurata M, Masumoto J, Takenaka K, Yasukawa M.
- Organizer
  The 82nd JSH Annual Meeting
- Data Source
  KAKENHI-PROJECT-18H02839
[Presentation] Next-generation CAR T-cell therapy using antitumor scFvs optimized by a cell-based screening system2019
- Author(s)
  Ochi, T., Maruta, M., Tanimoto, K., Fujiwara, H., Takenaka, K., Yasukawa, M.
- Organizer
  The 81 st Annual Meeting of the Japanese Society of Hematology
- Invited
- Data Source
  KAKENHI-PROJECT-18H02839
[Presentation] Establishment of a novel T-cell-based scFv screening technology to advance modified antibody-based immunotherapy2019
- Author(s)
  Ochi, T., Maruta, M., Tanimoto, K., Fujiwara, H., Takenaka, K., Yasukawa, M.
- Organizer
  The 17 th Annual Meeting of the Association for Cancer Immunotherapy (CIMT)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18H02839
[Presentation] Establishment of a novel T-cell-based scFv screening technology to advance modified antibody-based immunotherapy.2019
- Author(s)
  Ochi T, Maruta M, Tanimoto K, Fujiwara H, Takenaka K, Yasukawa M
- Organizer
  The 17th Annual Meeting of the Association for Cancer Immunotherapy (CIMT)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08331
[Presentation] Development of next-generation CAR-T cell therapy using antitumor scFvs optimized by a novel cell-based screening system.2019
- Author(s)
  越智俊元, 丸田雅樹, 谷本一史, 藤原弘, 竹中克斗, 安川正貴
- Organizer
  第11回日本血液疾患免疫療法学会学術集会
- Data Source
  KAKENHI-PROJECT-18K08331
[Presentation] 免疫療法の未来を拓く次世代型抗体の開発とその応用2019
- Author(s)
  越智俊元
- Organizer
  日本骨髄腫学会第1回骨髄腫セミナー
- Invited
- Data Source
  KAKENHI-PROJECT-18K08331
[Presentation] キメラ抗原受容体導入細胞傷害性T細胞におけるCD8分子の役割2019
- Author(s)
  近藤史孟, 越智俊元, 丸田雅樹, 谷本一史, 竹中克斗, 安川正貴
- Organizer
  第116回日本内科学会総会
- Data Source
  KAKENHI-PROJECT-18K08331
[Presentation] Next-generation CAR T-cell therapy using antitumor scFvs optimized by a cell-based screening system.2019
- Author(s)
  Ochi T, Maruta M, Tanimoto K, Fujiwara H, Takenaka K, Yasukawa M
- Organizer
  The 81st Annual Meeting of the Japanese Society of Hematology
- Data Source
  KAKENHI-PROJECT-18K08331
[Presentation] A novel scFv screening technology by exploiting T cells in combination with CAR-based scFv library.2019
- Author(s)
  越智俊元, 丸田雅樹, 谷本一史, 藤原弘, 竹中克斗, 安川正貴
- Organizer
  第23回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K08331
[Presentation] 臨床ニーズに即したがん免疫療法を目指す新規改変抗体の開発研究2018
- Author(s)
  越智俊元, 丸田雅樹, 谷本一史, 朝井洋晶, 斉藤卓, 今村健志, 竹中克斗, 安川正貴
- Organizer
  第6回TR推進合同フォーラム・ライフサイエンス技術交流会
- Data Source
  KAKENHI-PROJECT-18K08331
[Presentation] Generation of optimal antitumor receptors for T-cell therapy in hematological malignancies. Symposium 7, -Rising star in JSH-2018
- Author(s)
  Toshiki Ochi
- Organizer
  The 80th Annual Meeting of the Japanese Society of Hematology
- Invited
- Data Source
  KAKENHI-PROJECT-18K08331
[Presentation] 難治性骨髄腫を標的とした改変抗体T細胞免疫療法2018
- Author(s)
  丸田雅樹, 越智俊元, 谷本一史, 東太地, 斉藤卓, 藤原弘, 今村健志, 安川正貴
- Organizer
  第80回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18H02839
[Presentation] Anti-myeloma T-cell therapy by exploiting modified antibodies specific for A2/NY-ESO-12018
- Author(s)
  Ochi, T.
- Organizer
  4th Annual Immunotherapy in Myeloma Scientific Workshop
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H07025
[Presentation] 改変抗体を用いた難治性骨髄腫に対する新規T細胞免疫療法の開発2018
- Author(s)
  丸田雅樹, 越智俊元, 谷本一史, 東太地, 齋藤卓, 藤原弘, 今村健志, 安川正貴
- Organizer
  第22回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18H02839
[Presentation] 改変抗体を応用した難治性骨髄腫に対する新規T細胞免疫療法の開発2018
- Author(s)
  越智俊元, 丸田雅樹, 谷本一史, 朝井洋晶, 斉藤卓, 藤原弘, 今村健志, 竹中克斗, 安川正貴
- Organizer
  第10回血液疾患免疫療法学会学術集会
- Data Source
  KAKENHI-PROJECT-18H02839
[Presentation] Development of anti-myeloma immunotherapy by exploiting modified antibodies specific for A2/NY-ESO-12018
- Author(s)
  4)Ochi, T., Maruta, M., Tanimoto, K., Asai, H., Saitou, T., Yakushijin, Y., Fujiwara, H., Imamura,T., Takenaka, K., Yasukawa, M.
- Organizer
  The fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18H02839
[Presentation] 改変抗体を応用したがんに対する新規免疫療法の開発研究2018
- Author(s)
  越智俊元
- Organizer
  第2回先進医薬研究報告会
- Data Source
  KAKENHI-PROJECT-18K08331
[Presentation] Development of T-cell therapy by exploiting modified antibodies specific for A2/NY-ESO-1 for refractory myeloma2017
- Author(s)
  Maruta, M., Ochi, T., Tanimoto, K., Azuma, T., Fujiwara, H., Yasukawa, M.
- Organizer
  The 59th American Society of Hematology Annual Meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H07025
[Presentation] 造血器腫瘍に対する抗原特異的T細胞を用いた免疫遺伝子治療2017
- Author(s)
  越智俊元
- Organizer
  第45回日本臨床免疫学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-16H07025
[Presentation] Strategically Comprehensive Immunotherapy Utilizing Modified Antibody Targeting NY-ESO-1 for Myeloma2017
- Author(s)
  Maruta, M., Ochi, T., Fujiwara, H., Yasukawa, M.
- Organizer
  The 8th JSH International Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H07025
[Presentation] NY-ESO-1を認識する改変抗体を応用した骨髄腫に対する新たな包括的免疫療法の開発2017
- Author(s)
  越智俊元, 丸田雅樹, 藤原弘, 安川正貴
- Organizer
  第54回日本臨床分子医学会学術集会
- Data Source
  KAKENHI-PROJECT-16H07025
[Presentation] Development of immunotherapy for myeloma utilizing T cells redirected with modified antibodies specific for NY-ESO-12017
- Author(s)
  Ochi, T., Maruta, M., Tanimoto, K., Azuma, T., Fujiwara, H., Yasukawa M.
- Organizer
  The 36th Sapporo International Cancer Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H07025
[Presentation] 改変抗体を応用した多発性骨髄腫に対する新たな免疫療法の開発2017
- Author(s)
  丸田雅樹, 越智俊元, 藤原弘, 安川正貴
- Organizer
  第79回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-16H07025
[Presentation] T細胞を応用した造血器腫瘍に対する免疫療法2017
- Author(s)
  越智俊元
- Organizer
  平成29年度高知大学大学院医学専攻DCセミナー
- Invited
- Data Source
  KAKENHI-PROJECT-16H07025
[Presentation] A2/NY-ESO-1特異的改変抗体を応用した多発性骨髄腫に対する新規免疫療法の開発2017
- Author(s)
  丸田雅樹, 越智俊元, 谷本一史, 東太地, 藤原弘, 安川正貴
- Organizer
  第21回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-16H07025
[Presentation] Anti-myeloma immunotherapy utilizing T cells redirected by modified antibodies targeting NY-ESO-12017
- Author(s)
  Ochi, T., Maruta, M., Fujiwara, H., Yasukawa M.
- Organizer
  第42回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-16H07025
[Presentation] A2/NY-ESO-1特異的改変抗体を応用した骨髄腫に対する新たな免疫療法の開発2017
- Author(s)
  越智俊元, 丸田雅樹, 谷本一史, 東太地, 藤原弘, 安川正貴
- Organizer
  第9回血液疾患免疫療法学会
- Data Source
  KAKENHI-PROJECT-16H07025
[Presentation] DEVELOPMENT OF ANTI-LEUKEMIA GENE-IMMUNOTHERAPY USING AURORA-A KINASE-SPECIFIC T-CELL RECEPTOR GENE TRANSFER2010
- Author(s)
  越智俊元
- Organizer
  第16回日本遺伝子治療学会
- Place of Presentation
  宇都宮、栃木
- Year and Date
  2010-07-01
- Data Source
  KAKENHI-PROJECT-22790913

1. YASUKAWA MASAKI (60127917)

# of Collaborated Projects: 2 results

# of Collaborated Products: 18 results
2. 山田武司 (40333554)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
3. KURATA Mie

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
4. 朝井洋晶

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Ochi Toshiki 越智 俊元

越智 俊元 オチ トシキ

Research Projects

Research Products

Co-Researchers

新たなT細胞活性化シグナルに基づく新規キメラ抗原受容体の開発研究Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of multifunctional CAR-T cell therapy using novel manufacturing technology of scFv

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a novel single-chain antibody which regulates cytokine signalingPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of Next-Generation Immunotherapy using Antitumor Antibodies armed with Bridging-BiTE against Refractory TumorsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development and clinical application of cancer-specific single-chain antibody using new technology of antibody modification

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Generation of chimeric antigen receptors with different reactivity for a tumor antigenPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Aurora－Aを標的とした包括的がん免疫療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] Methods in Molecular Biology.2019

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] 血液疾患 最新の治療2020-20222019

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] 実験医学2019

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Journal Article] Reinforced antimyeloma therapy via dual-lymphoid activation mediated by a panel of antibodies armed with bridging-BiTE2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A single-chain antibody generation system yielding CAR-T cells with superior antitumor function2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Development of innovative T-cell immunotherapy for hematological malignancies2019

Author(s)

Journal Title

DOI

NAID

Ochi Toshiki 越智俊元

越智俊元オチトシキ

[Book] 血液疾患最新の治療2020-20222019

[Journal Article] 造血器腫瘍に対する免疫療法　新たな標的抗原とその治療応用2019